The Biology of APBD & Getting the Right Diagnosis

The journey to an APBD diagnosis is often a biological puzzle. Because the disease is so rare, symptoms are frequently attributed to more common conditions like prostate enlargement or Multiple Sclerosis (MS). Understanding the specific biological mechanism that causes APBD—and the unique patterns it leaves on medical tests—is the key to ensuring you have the right diagnosis.

The Biological Problem: A Branching Defect

In a healthy body, sugar is stored in the liver and muscles as glycogen. To keep glycogen compact and easy for the body to use, the glycogen branching enzyme acts to “branch” the sugar molecules into a complex, tree-like structure.

In APBD, mutations in the GBE1 gene result in a deficiency of this enzyme ^[1]. Without proper branching, the glycogen becomes abnormally long, stiff, and insoluble, forming polyglucosan bodies ^[2].

Over time, these bodies build up inside neurons (nerve cells) and astrocytes (cells that support nerves), triggering gliosis (scarring) and inflammation ^[2][3]. Eventually, this leads to neurodegeneration, where the nerves in the brain, spinal cord, and limbs lose their ability to send signals ^[2].

Why the Right Diagnosis is Often Delayed

APBD is frequently mistaken for other diseases because its symptoms overlap with common issues.

• Prostate Disease: Many men with APBD are first diagnosed with prostate disease ^[4]. The buildup of polyglucosan bodies damages the nerves controlling the bladder, causing a neurogenic bladder ^[4][5]. In a 30-patient study, 60% of the men had their urinary issues blamed solely on their prostate, and some underwent surgery that did not fix the problem ^[4]. It is important to remember that prostate enlargement and APBD can coexist; an expert neuro-urologist can help determine what is causing your symptoms.
• Multiple Sclerosis (MS): On an MRI, APBD creates leukoencephalopathy (white matter abnormalities) that can look like the lesions seen in MS ^[4]. However, APBD lesions are often paired with significant cervical spinal cord atrophy (thinning of the spinal cord in the neck) ^[4][6]. While an MRI alone cannot definitively rule out MS, this pattern strongly suggests APBD when paired with the right clinical symptoms.
• ALS and Peripheral Neuropathy: APBD can look like ALS because it shows “mixed” signs: spasticity (stiffness) from upper motor neurons in the brain/spine, and peripheral neuropathy (numbness/weakness) from lower motor neurons in the legs ^[4][5].

Tests That Support and Confirm the Diagnosis

Diagnosis usually requires a combination of clinical symptoms, supportive tests, and molecular confirmation.

1. Findings That Support Suspicion:

• Specialized MRI: Radiologists look for extensive white matter changes in the brain combined with visible thinning of the medulla and cervical spinal cord ^[4][7].
• Electrodiagnostics (EMG/NCS): These tests evaluate nerve function and often show a length-dependent sensorimotor polyneuropathy, meaning the nerves furthest from the spine (in the feet) are most damaged ^[4][5].

2. Tests That Establish the Diagnosis:

• Genetic Testing (Confirmation): Finding biallelic (two) pathogenic or likely pathogenic variants in the GBE1 gene is the standard way to confirm APBD. However, standard panels sometimes miss deep intronic variants (mutations hidden in non-coding DNA) ^[8][9]. If your doctor strongly suspects APBD but only one variant is found, they may order broader testing or refer you to a geneticist.
• Enzyme or Tissue Testing: If genetic testing is unresolved (such as finding a “variant of uncertain significance”), a doctor may test the activity of the glycogen branching enzyme in skin fibroblasts or blood cells. While residual enzyme activity of 5% to 20% is often associated with adult-onset disease, this is not a strict cutoff and depends on the specific laboratory assay ^[2]. A nerve biopsy showing polyglucosan bodies can also support the diagnosis, but it is invasive and not routinely required if genetics are clear ^[10].